4579.T
RaQualia Pharma Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 550.00
+0.92%Year over year
Reported trailing growth
- Revenue
- +28.1%
- EBITDA
- +4739.9%
- EBIT
- +326.8%
- EPS
- +147.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -2.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +10.9%
- EBITDA
- -12.2%
- EBIT
- -17.7%
- Net income
- -27.7%
- EPS
- -30.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026